BioCryst: 4Q Earnings Snapshot

DURHAM, N.C. (AP) _ BioCryst Pharmaceuticals Inc. (BCRX) on Thursday reported a loss of $60.5 million in its fourth quarter.

The Durham, North Carolina-based company said it had a loss of 34 cents per share.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The drugmaker posted revenue of $4 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $14.7 million.

For the year, the company reported that its loss widened to $182.8 million, or $1.09 per share. Revenue was reported as $17.8 million.

BioCryst shares have increased 59% since the beginning of the year. The stock has more than quadrupled in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at https://www.zacks.com/ap/BCRX